PK

Priyanka Kumari

Active Director Director DIN 08922642
DIN 08922642 First appointment Oct 2020 Primary industry Trading
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Oct 2020
Shareholding value •••• Premium profile

About Priyanka Kumari

Data last updated:

Priyanka Kumari is a Director at Cocoon Pharmaceuticals Private Limited (since 2020). The company operates in Trading. Cocoon Pharmaceuticals Private Limited reported revenue of ₹12.2 Lakh (FY 2022).

DIN 08922642
Primary Designation Director
Industry Trading
First Appointment 16 Oct 2020
Oldest Company Age 6 yrs
Largest company Cocoon Pharmaceuticals Private Limited · ₹12.2 Lakh (FY 2022)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director16 Oct 20202020₹12.2 Lakh (FY 2022)Under Process Of Striking Off

Board colleagues of Priyanka Kumari

Directorship timeline

Open interactive timeline →
Cocoon Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Priyanka Kumari

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Priyanka Kumari

Priyanka Kumari currently holds 1 directorship: Cocoon Pharmaceuticals Private Limited (Director, since 16 Oct 2020, revenue ₹12.2 Lakh (FY 2022)).

Priyanka Kumari was first appointed on 16 Oct 2020 as Director at Cocoon Pharmaceuticals Private Limited.

The current boards of Priyanka Kumari's companies include Simmi Kumari Verma (Cocoon Pharmaceuticals Private Limited), Sudha Kumar (Cocoon Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available